Structure and activation mechanisms of G protein-coupled and atypical chemokine receptors
From: Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacology, University of California, San Diego (US) Host contact: Davide Robbiani Date: 09.12.2021 17:00 Speakers: Tracy Handel Virtual Conference
Inauguration – 27.11.2021 – Live streaming
The inauguration has been streamed live. You can watch the video by clicking on the picture below.
The Helmut Horten Foundation awards a special collaborative grant to IOR and IRB researchers on the occasion of its 50th anniversary
Bellinzona, November 4th, 2021 – On October 22, 2021, the Helmut Horten Foundation celebrated its 50th anniversary with a ceremony at ETH, in Zurich. On this occasion, researchers of IOR and IRB (Institute of Oncology Research and Institute for Research in Biomedicine, both affiliated to Università della Svizzera italiana) were awarded a special “jubilee grant” […]
Immune responses to SARS-CoV-2
From: Howard Hughes Medical Institute, Yale University School of Medicine, Department of Immunobiology, New Haven (US) Host contact: Roger Geiger Date: 18.11.2021 16:30 Speakers: Akiko Iwasaki Virtual Conference
Engineered bacteria for cancer immunotherapy
Bellinzona, October 6th, 2021 – A Nature paper by the Systems Immunology group, headed by Roger Geiger, at the Institute for Research in Biomedicine (IRB, affiliated to USI). This study describes an innovative strategy to improve the anti-tumor activity of T cells, key players of the immune system with the ability to detect and kill […]
New SNSF grants awarded to three IRB researchers
Bellinzona – September 28, 2021 – The Swiss National Science Foundation (SNSF) has recently awarded three group leaders at the Institute for Research in Biomedicine (IRB, affiliated to USI): Silvia Monticelli, Santiago González and Petr Cejka. Silvia Monticelli, director of the Molecular Immunology lab, is interested in studying gene expression regulation in immune cells at […]
The IRB Student Association (ISA) is born
24.09.2021 – The IRB warmly welcome the newly created IRB Student Association (ISA). The association’s main aim is to promote interaction between IRB students, facilitate student life, and advocate the interests of students. The IRB thanks Emina, Elaheh, Irene, Serena, Julia, Edisa, Giulia, Tommaso and Ian, members of the ISA steering committee.
First peptide inhibitor of the CXCL12/HMGB1 heterocomplex identified
During inflammatory reactions, the production and release of chemotactic factors guide the recruitment of selective leukocyte subpopulations. The chemokine CXCL12 and the alarmin HMGB1, both released in the microenvironment, can form a heterocomplex, which exclusively acts on the chemokine receptor CXCR4, enhancing cell migration and, in some pathological conditions such as Rheumatoid Arthritis exacerbates the […]
The Association Bellinzona Institutes of Science (Bios+) is born
Bellinzona, September 15th, 2021 – the Foundations of the Institute for Research in Biomedicine (IRB) and the Institute of Oncology Research (IOR) presented the newly formed association Bellinzona Institutes of Science (Bios+), which was established by the two Institutes on July 21st with the aim of promoting and coordinating research activities and creating scientific and […]
IRB ready for clinical testing of second generation antibody against COVID-19
Bellinzona, September 7, 2021 – Following the development of a second-generation antibody against the novel coronavirus (SARS-CoV-2) and its variants, the Institute for Research in Biomedicine (IRB, affiliated to USI) is now moving into the clinical trial phase, supported by the European Commission. Described in a paper published in March in the prestigious journal Nature, […]
